Takeda Pharmaceutical Company Limited Stock
Stocks
4502
JP3463000004
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,448.00 JPY | -1.25% |
|
+5.26% | +12.68% |
| 07-02 | Asian Equities Traded in the US as American Depositary Receipts Surge in Thursday Trading | MT |
| 07-02 | Takeda, Insilico Sign AI-Driven Drug Discovery Pact | MT |
| Market Cap | 8,607B 53.06B 46.52B 42.92B 39.76B 75.35B 5,042B 76.66B 510B 200B 2,486B 199B 195B | P/E 2027 * |
44.3x | P/E 2028 * | 28.4x |
|---|---|---|---|---|---|
| Enterprise Value | 12,493B 77.02B 67.52B 62.29B 57.7B 109B 7,317B 111B 741B 290B 3,608B 289B 283B | EV / Sales 2027 * |
2.7x | EV / Sales 2028 * | 2.63x |
| Free-Float |
99.25% | Yield 2027 * |
3.75% | Yield 2028 * | 3.82% |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | -1.25% | ||
| 1 week | +5.26% | ||
| Current month | +5.68% | ||
| 1 month | +10.60% | ||
| 3 months | -5.32% | ||
| 6 months | +10.89% | ||
| Current year | +12.68% |
| 1 week | 5,112 |  | 5,517 |
| 1 month | 4,896 | | 5,517 |
| Current year | 4,710 | | 6,033 |
| 1 year | 4,102 | | 6,033 |
| 3 years | 3,852 | | 6,033 |
| 5 years | 2,993 | | 6,033 |
| 10 years | 2,894.5 | | 6,693 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 24/06/2026 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 01/04/2024 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 47 | 01/02/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 60 | 01/06/2015 |
Steven Gillis
BRD | Director/Board Member | 73 | 01/01/2019 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 01/06/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-24 | Other | Director | 795 | 0.0000% | ||
| 04-27 | Free | Chief Technology Officer | 212,470 | 0.0134% | ||
| 04-27 | Free | Chief Financial Officer | 15,614 | 0.0010% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.25% | +5.26% | +22.70% | +21.26% | 53.69B | |
| +2.96% | +3.01% | +59.87% | +173.31% | 1,070B | |
| +3.05% | +5.23% | +72.11% | +67.81% | 624B | |
| -0.04% | +1.20% | +35.72% | +87.93% | 450B | |
| -2.58% | -2.07% | +27.62% | +22.57% | 328B | |
| +1.36% | +0.17% | +29.90% | +49.33% | 284B | |
| +1.98% | +4.08% | -25.78% | -39.02% | 217B | |
| +0.45% | +1.65% | +25.65% | +68.35% | 198B | |
| +5.21% | +7.93% | +21.99% | +83.23% | 161B | |
| +1.48% | -0.04% | -4.64% | -32.25% | 135B | |
| Average | +0.65% | +2.64% | +26.51% | +50.25% | 352.12B | |
| Weighted average by Cap. | +0.27% | +2.57% | +41.55% | +86.34% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,630B 28.55B 25.03B 23.09B 21.39B 40.53B 2,712B 41.24B 274B 107B 1,337B 107B 105B | 4,701B 28.98B 25.41B 23.44B 21.71B 41.15B 2,753B 41.86B 279B 109B 1,358B 109B 106B |
| Net income | 184B 1.13B 994M 917M 849M 1.61B 108B 1.64B 10.9B 4.26B 53.11B 4.26B 4.17B | 309B 1.91B 1.67B 1.54B 1.43B 2.71B 181B 2.75B 18.34B 7.17B 89.33B 7.16B 7.01B |
| Net Debt | 3,886B 23.95B 21B 19.37B 17.95B 34.01B 2,276B 34.61B 230B 90.07B 1,122B 89.95B 88.01B | 3,750B 23.12B 20.27B 18.7B 17.32B 32.83B 2,197B 33.4B 222B 86.93B 1,083B 86.82B 84.95B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/07/26 | ¥5,448.00 | -1.25% | 3,488,200 |
| 06/07/26 | ¥5,517.00 | +2.95% | 3,686,800 |
| 03/07/26 | ¥5,359.00 | +1.61% | 4,074,200 |
| 02/07/26 | ¥5,274.00 | +2.41% | 3,538,100 |
| 01/07/26 | ¥5,150.00 | -0.10% | 4,177,200 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4502 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
